Invention Grant
- Patent Title: Bi-heteroaryl substitute 1,4-benzodiazepines and uses thereof for the treatment of cancer
-
Application No.: US15762552Application Date: 2016-09-22
-
Publication No.: US11542247B2Publication Date: 2023-01-03
- Inventor: Patrick Rene Angibaud , Diego Fernando Domenico Broggini , Filip Albert C Cuyckens , Steven Anna Hostyn , Russell Mark Jones , Olivier Alexis Georges Querolle , Wim Vermeulen
- Applicant: Janssen Pharmaceutica NV
- Applicant Address: BE Beerse
- Assignee: Janssen Pharmaceutica NV
- Current Assignee: Janssen Pharmaceutica NV
- Current Assignee Address: BE Beerse
- Agency: BakerHostetler
- Priority: EP15186478 20150923
- International Application: PCT/EP2016/072501 WO 20160922
- International Announcement: WO2017/050865 WO 20170330
- Main IPC: C07D401/14
- IPC: C07D401/14 ; A61P35/00 ; C07D471/04 ; C07D403/14
Abstract:
The invention relates to new quinoline, pyridopyrazine, naphthyridine and quinazolinone derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
Public/Granted literature
- US20200255401A1 NEW COMPOUNDS Public/Granted day:2020-08-13
Information query
